Congress Must Act to Prevent Anti-Competitive Tactics Used by Many Major Pharmaceutical Companies to Keep Low-Cost Alternatives Out of the Marketplace WASHINGTON D.C. – The Coalition Against Patent Abuse released the following statement after the House Judiciary Committee passed three bills relating to patent reform and drug pricing, including H.R. 2873, the Affordable Prescriptions for Patients Through […]

Continue Reading

The “Restoring the America Invents Act” Aims to Reduce Big Pharma’s Manipulation of the Patent System and Strengthen Tools Such as the Inter Partes Review Process to Increase Patent Quality  WASHINGTON D.C. – The Coalition Against Patent Abuse (CAPA) released the following statement after Senator Patrick Leahy (D-VT) and Senator John Cornyn (R-TX) introduced the “Restoring […]

Continue Reading

WHAT YOU NEED TO KNOW: CAPA Highlights 10th Anniversary of the America Invents Act and the Creation of the Inter Partes Review (IPR) Process Since its creation, IPR has saved over $2 billion in deadweight loss by reducing the cost of determining patent validity and has also been used to invalidate patents that were weaponized […]

Continue Reading